Efficacy of Qualia Testosterone+ on Testosterone Levels in Adult Males
NCT07556458
This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
This is a double-blind, placebo-controlled, triple-arm, parallel-group study evaluating the efficacy and tolerability of two distinct Qualia Testosterone+ formulations, novel dietary supplements formulated to support endogenous testosterone, in adult males aged 28-65. Approximately 75 participants will be assigned equally to receive Qualia Testosterone+ Formula 1, Qualia Testosterone+ Formula 2, or a matched placebo (3 capsules once each morning) for 28 days. The primary outcome is between-group change in total testosterone from baseline to day 28.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Low Testosterone Levels
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Not applicable
- Ages
- 28 to 65 years
- Sex
- Male
- Healthy volunteers
- Accepted
- Sponsor
- Qualia Life Sciences
- Last updated on ClinicalTrials.gov
- October 5, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
California · 1
- Qualia Life Sciences · Carlsbad, CA
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.